Cytomx Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Cytomx Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cytomx Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytomx Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $96k | 30k | 3.19 |
| 2025-06-30 | $926k | 408k | 2.27 |
| 2025-03-31 | $475k | 747k | 0.64 |
| 2024-12-31 | $524k | 509k | 1.03 |
| 2024-09-30 | $82k | 69k | 1.18 |
| 2024-06-30 | $86k | 70k | 1.22 |
| 2024-03-31 | $45k | 21k | 2.18 |
| 2023-12-31 | $31k | 20k | 1.55 |
| 2023-09-30 | $24k | 19k | 1.29 |
| 2023-06-30 | $37k | 21k | 1.72 |
| 2023-03-31 | $41k | 27k | 1.51 |
| 2022-12-31 | $73k | 46k | 1.60 |
| 2022-09-30 | $27k | 18k | 1.49 |
| 2022-06-30 | $8.0k | 4.2k | 1.90 |
| 2022-03-31 | $5.0k | 1.7k | 2.93 |
| 2021-12-31 | $576k | 141k | 4.10 |
| 2021-09-30 | $783k | 157k | 4.98 |
| 2021-06-30 | $157k | 25k | 6.23 |
| 2021-03-31 | $630k | 82k | 7.73 |
| 2020-12-31 | $9.0k | 1.4k | 6.39 |
| 2020-09-30 | $8.0k | 1.2k | 6.67 |
| 2020-06-30 | $10k | 1.2k | 8.33 |
| 2020-03-31 | $174k | 23k | 7.66 |
| 2019-12-31 | $458k | 57k | 8.00 |
| 2019-09-30 | $658k | 89k | 7.38 |
| 2019-06-30 | $262k | 24k | 11.00 |
| 2019-03-31 | $131k | 12k | 10.89 |
| 2018-12-31 | $1.3M | 87k | 15.00 |
| 2018-09-30 | $219k | 12k | 18.50 |
| 2018-06-30 | $52k | 2.3k | 22.65 |
| 2018-03-31 | $1.3M | 46k | 28.49 |
| 2017-12-31 | $236k | 11k | 21.11 |
| 2017-09-30 | $278k | 15k | 18.14 |
| 2017-06-30 | $39k | 2.5k | 15.45 |
| 2017-03-31 | $53k | 3.0k | 17.27 |
| 2016-12-31 | $45k | 4.1k | 11.07 |
| 2016-09-30 | $14k | 876 | 15.98 |
| 2016-03-31 | $5.0k | 402 | 12.44 |
| 2015-12-31 | $14k | 664 | 21.08 |